Herb  ||| S:0 E:5 ||| JJ
network  ||| S:5 E:13 ||| NN
construction  ||| S:13 E:26 ||| NN
and  ||| S:26 E:30 ||| CC
co-module  ||| S:30 E:40 ||| JJ
analysis  ||| S:40 E:49 ||| NN
for  ||| S:49 E:53 ||| IN
uncovering  ||| S:53 E:64 ||| VBG
the  ||| S:64 E:68 ||| DT
combination  ||| S:68 E:80 ||| NN
rule  ||| S:80 E:85 ||| NN
of  ||| S:85 E:88 ||| IN
traditional  ||| S:88 E:100 ||| JJ
Chinese  ||| S:100 E:108 ||| JJ
herbal  ||| S:108 E:115 ||| JJ
formulae  ||| S:115 E:124 ||| JJ
Traditional  ||| S:124 E:136 ||| NNP
Chinese  ||| S:136 E:144 ||| NNP
Medicine  ||| S:144 E:153 ||| NNP
( ||| S:153 E:154 ||| -LRB-
TCM ||| S:154 E:157 ||| NNP
)  ||| S:157 E:159 ||| -RRB-
is  ||| S:159 E:162 ||| VBZ
characterized  ||| S:162 E:176 ||| VBN
by  ||| S:176 E:179 ||| IN
the  ||| S:179 E:183 ||| DT
wide  ||| S:183 E:188 ||| JJ
use  ||| S:188 E:192 ||| NN
of  ||| S:192 E:195 ||| IN
herbal  ||| S:195 E:202 ||| JJ
formulae ||| S:202 E:210 ||| NN
,  ||| S:210 E:212 ||| ,
which  ||| S:212 E:218 ||| WDT
are  ||| S:218 E:222 ||| VBP
capable  ||| S:222 E:230 ||| JJ
of  ||| S:230 E:233 ||| IN
systematically  ||| S:233 E:248 ||| RB
treating  ||| S:248 E:257 ||| VBG
diseases  ||| S:257 E:266 ||| NNS
determined  ||| S:266 E:277 ||| VBN
by  ||| S:277 E:280 ||| IN
interactions  ||| S:280 E:293 ||| NNS
among  ||| S:293 E:299 ||| IN
various  ||| S:299 E:307 ||| JJ
herbs ||| S:307 E:312 ||| NN
.  ||| S:312 E:314 ||| .
However ||| S:314 E:321 ||| RB
,  ||| S:321 E:323 ||| ,
the  ||| S:323 E:327 ||| DT
combination  ||| S:327 E:339 ||| NN
rule  ||| S:339 E:344 ||| NN
of  ||| S:344 E:347 ||| IN
TCM  ||| S:347 E:351 ||| NNP
herbal  ||| S:351 E:358 ||| JJ
formulae  ||| S:358 E:367 ||| NN
remains  ||| S:367 E:375 ||| VBZ
a  ||| S:375 E:377 ||| DT
mystery  ||| S:377 E:385 ||| NN
due  ||| S:385 E:389 ||| JJ
to  ||| S:389 E:392 ||| TO
the  ||| S:392 E:396 ||| DT
lack  ||| S:396 E:401 ||| NN
of  ||| S:401 E:404 ||| IN
appropriate  ||| S:404 E:416 ||| JJ
methods ||| S:416 E:423 ||| NNS
.  ||| S:423 E:425 ||| .
From  ||| S:425 E:430 ||| IN
a  ||| S:430 E:432 ||| DT
network  ||| S:432 E:440 ||| NN
perspective ||| S:440 E:451 ||| NN
,  ||| S:451 E:453 ||| ,
we  ||| S:453 E:456 ||| PRP
established  ||| S:456 E:468 ||| VBD
a  ||| S:468 E:470 ||| DT
method  ||| S:470 E:477 ||| NN
called  ||| S:477 E:484 ||| VBD
Distance-based  ||| S:484 E:499 ||| NNP
Mutual  ||| S:499 E:506 ||| NNP
Information  ||| S:506 E:518 ||| NNP
Model  ||| S:518 E:524 ||| NNP
( ||| S:524 E:525 ||| -LRB-
DMIM ||| S:525 E:529 ||| NNP
)  ||| S:529 E:531 ||| -RRB-
to  ||| S:531 E:534 ||| TO
identify  ||| S:534 E:543 ||| VB
useful  ||| S:543 E:550 ||| JJ
relationships  ||| S:550 E:564 ||| NNS
among  ||| S:564 E:570 ||| IN
herbs  ||| S:570 E:576 ||| NN
in  ||| S:576 E:579 ||| IN
numerous  ||| S:579 E:588 ||| JJ
herbal  ||| S:588 E:595 ||| JJ
formulae ||| S:595 E:603 ||| NN
.  ||| S:603 E:605 ||| .
DMIM  ||| S:605 E:610 ||| NNP
combines  ||| S:610 E:619 ||| VBZ
mutual  ||| S:619 E:626 ||| JJ
information  ||| S:626 E:638 ||| NN
entropy  ||| S:638 E:646 ||| NNS
and  ||| S:646 E:650 ||| CC
between-herb-distance  ||| S:650 E:672 ||| JJ
to  ||| S:672 E:675 ||| TO
score  ||| S:675 E:681 ||| VB
herb  ||| S:681 E:686 ||| JJ
interactions  ||| S:686 E:699 ||| NNS
and  ||| S:699 E:703 ||| CC
construct  ||| S:703 E:713 ||| VB
herb  ||| S:713 E:718 ||| JJ
network ||| S:718 E:725 ||| NN
.  ||| S:725 E:727 ||| .
To  ||| S:727 E:730 ||| TO
evaluate  ||| S:730 E:739 ||| VB
the  ||| S:739 E:743 ||| DT
efficacy  ||| S:743 E:752 ||| NN
of  ||| S:752 E:755 ||| IN
the  ||| S:755 E:759 ||| DT
DMIM-extracted  ||| S:759 E:774 ||| JJ
herb  ||| S:774 E:779 ||| NN
network ||| S:779 E:786 ||| NN
,  ||| S:786 E:788 ||| ,
we  ||| S:788 E:791 ||| PRP
conducted  ||| S:791 E:801 ||| VBD
in  ||| S:801 E:804 ||| IN
vitro  ||| S:804 E:810 ||| JJ
assays  ||| S:810 E:817 ||| NN
to  ||| S:817 E:820 ||| TO
measure  ||| S:820 E:828 ||| VB
the  ||| S:828 E:832 ||| DT
activities  ||| S:832 E:843 ||| NNS
of  ||| S:843 E:846 ||| IN
strongly  ||| S:846 E:855 ||| RB
connected  ||| S:855 E:865 ||| VBN
herbs  ||| S:865 E:871 ||| NNS
and  ||| S:871 E:875 ||| CC
herb  ||| S:875 E:880 ||| JJ
pairs ||| S:880 E:885 ||| NNS
.  ||| S:885 E:887 ||| .
Moreover ||| S:887 E:895 ||| RB
,  ||| S:895 E:897 ||| ,
using  ||| S:897 E:903 ||| VBG
the  ||| S:903 E:907 ||| DT
networked  ||| S:907 E:917 ||| JJ
Liu-wei-di-huang  ||| S:917 E:934 ||| NN
( ||| S:934 E:935 ||| -LRB-
LWDH ||| S:935 E:939 ||| NNP
)  ||| S:939 E:941 ||| -RRB-
formula  ||| S:941 E:949 ||| NN
as  ||| S:949 E:952 ||| IN
an  ||| S:952 E:955 ||| DT
example ||| S:955 E:962 ||| NN
,  ||| S:962 E:964 ||| ,
we  ||| S:964 E:967 ||| PRP
proposed  ||| S:967 E:976 ||| VBD
a  ||| S:976 E:978 ||| DT
novel  ||| S:978 E:984 ||| NN
concept  ||| S:984 E:992 ||| NN
of  ||| S:992 E:995 ||| IN
co-module  ||| S:995 E:1005 ||| JJ
across  ||| S:1005 E:1012 ||| IN
herb-biomolecule-disease  ||| S:1012 E:1037 ||| JJ
multilayer  ||| S:1037 E:1048 ||| JJ
networks  ||| S:1048 E:1057 ||| NNS
to  ||| S:1057 E:1060 ||| TO
explore  ||| S:1060 E:1068 ||| VB
the  ||| S:1068 E:1072 ||| DT
potential  ||| S:1072 E:1082 ||| JJ
combination  ||| S:1082 E:1094 ||| NN
mechanism  ||| S:1094 E:1104 ||| NN
of  ||| S:1104 E:1107 ||| IN
herbal  ||| S:1107 E:1114 ||| JJ
formulae ||| S:1114 E:1122 ||| NN
.  ||| S:1122 E:1124 ||| .
DMIM ||| S:1124 E:1128 ||| NNP
,  ||| S:1128 E:1130 ||| ,
when  ||| S:1130 E:1135 ||| WRB
used  ||| S:1135 E:1140 ||| VBN
for  ||| S:1140 E:1144 ||| IN
retrieving  ||| S:1144 E:1155 ||| JJ
herb  ||| S:1155 E:1160 ||| NN
pairs ||| S:1160 E:1165 ||| NNS
,  ||| S:1165 E:1167 ||| ,
achieves  ||| S:1167 E:1176 ||| VBZ
a  ||| S:1176 E:1178 ||| DT
good  ||| S:1178 E:1183 ||| JJ
balance  ||| S:1183 E:1191 ||| NN
among  ||| S:1191 E:1197 ||| IN
the  ||| S:1197 E:1201 ||| DT
herb ||| S:1201 E:1205 ||| NN
's  ||| S:1205 E:1208 ||| POS
frequency ||| S:1208 E:1217 ||| NN
,  ||| S:1217 E:1219 ||| ,
independence ||| S:1219 E:1231 ||| NN
,  ||| S:1231 E:1233 ||| ,
and  ||| S:1233 E:1237 ||| CC
distance  ||| S:1237 E:1246 ||| NN
in  ||| S:1246 E:1249 ||| IN
herbal  ||| S:1249 E:1256 ||| JJ
formulae ||| S:1256 E:1264 ||| NN
.  ||| S:1264 E:1266 ||| .
A  ||| S:1266 E:1268 ||| DT
herb  ||| S:1268 E:1273 ||| JJ
network  ||| S:1273 E:1281 ||| NN
constructed  ||| S:1281 E:1293 ||| VBN
by  ||| S:1293 E:1296 ||| IN
DMIM  ||| S:1296 E:1301 ||| NNP
from  ||| S:1301 E:1306 ||| IN
3865  ||| S:1306 E:1311 ||| CD
Collaterals-related  ||| S:1311 E:1331 ||| JJ
herbal  ||| S:1331 E:1338 ||| JJ
formulae  ||| S:1338 E:1347 ||| NN
can  ||| S:1347 E:1351 ||| MD
not  ||| S:1351 E:1355 ||| RB
only  ||| S:1355 E:1360 ||| RB
nicely  ||| S:1360 E:1367 ||| RB
recover  ||| S:1367 E:1375 ||| VB
traditionally-defined  ||| S:1375 E:1397 ||| JJ
herb  ||| S:1397 E:1402 ||| NN
pairs  ||| S:1402 E:1408 ||| NNS
and  ||| S:1408 E:1412 ||| CC
formulae ||| S:1412 E:1420 ||| NN
,  ||| S:1420 E:1422 ||| ,
but  ||| S:1422 E:1426 ||| CC
also  ||| S:1426 E:1431 ||| RB
generate  ||| S:1431 E:1440 ||| VB
novel  ||| S:1440 E:1446 ||| JJ
anti-angiogenic  ||| S:1446 E:1462 ||| JJ
herb  ||| S:1462 E:1467 ||| NN
ingredients  ||| S:1467 E:1479 ||| NNS
( ||| S:1479 E:1480 ||| -LRB-
e.g.  ||| S:1480 E:1485 ||| NNP
Vitexicarpin  ||| S:1485 E:1498 ||| NNP
with  ||| S:1498 E:1503 ||| IN
IC50=3.2  ||| S:1503 E:1512 ||| NNP
μM ||| S:1512 E:1514 ||| NNP
,  ||| S:1514 E:1516 ||| ,
and  ||| S:1516 E:1520 ||| CC
Timosaponin  ||| S:1520 E:1532 ||| NNP
A-III  ||| S:1532 E:1538 ||| NNP
with  ||| S:1538 E:1543 ||| IN
IC50=3.4  ||| S:1543 E:1552 ||| NNP
μM ||| S:1552 E:1554 ||| NNP
)  ||| S:1554 E:1556 ||| -RRB-
as  ||| S:1556 E:1559 ||| IN
well  ||| S:1559 E:1564 ||| RB
as  ||| S:1564 E:1567 ||| IN
herb  ||| S:1567 E:1572 ||| JJ
pairs  ||| S:1572 E:1578 ||| NNS
with  ||| S:1578 E:1583 ||| IN
synergistic  ||| S:1583 E:1595 ||| NN
or  ||| S:1595 E:1598 ||| CC
antagonistic  ||| S:1598 E:1611 ||| JJ
effects ||| S:1611 E:1618 ||| NNS
.  ||| S:1618 E:1620 ||| .
Based  ||| S:1620 E:1626 ||| VBN
on  ||| S:1626 E:1629 ||| IN
gene  ||| S:1629 E:1634 ||| NN
and  ||| S:1634 E:1638 ||| CC
phenotype  ||| S:1638 E:1648 ||| JJ
information  ||| S:1648 E:1660 ||| NN
associated  ||| S:1660 E:1671 ||| VBN
with  ||| S:1671 E:1676 ||| IN
both  ||| S:1676 E:1681 ||| DT
LWDH  ||| S:1681 E:1686 ||| NNP
herbs  ||| S:1686 E:1692 ||| NN
and  ||| S:1692 E:1696 ||| CC
LWDH-treated  ||| S:1696 E:1709 ||| JJ
diseases ||| S:1709 E:1717 ||| NNS
,  ||| S:1717 E:1719 ||| ,
we  ||| S:1719 E:1722 ||| PRP
found  ||| S:1722 E:1728 ||| VBD
that  ||| S:1728 E:1733 ||| DT
LWDH-treated  ||| S:1733 E:1746 ||| JJ
diseases  ||| S:1746 E:1755 ||| NNS
show  ||| S:1755 E:1760 ||| VBP
high  ||| S:1760 E:1765 ||| JJ
phenotype  ||| S:1765 E:1775 ||| JJ
similarity  ||| S:1775 E:1786 ||| NN
and  ||| S:1786 E:1790 ||| CC
identified  ||| S:1790 E:1801 ||| VBN
certain  ||| S:1801 E:1809 ||| JJ
co-modules  ||| S:1809 E:1820 ||| JJ
enriched  ||| S:1820 E:1829 ||| NN
in  ||| S:1829 E:1832 ||| IN
cancer  ||| S:1832 E:1839 ||| NN
pathways  ||| S:1839 E:1848 ||| NNS
and  ||| S:1848 E:1852 ||| CC
neuro-endocrine-immune  ||| S:1852 E:1875 ||| JJ
pathways ||| S:1875 E:1883 ||| NN
,  ||| S:1883 E:1885 ||| ,
which  ||| S:1885 E:1891 ||| WDT
may  ||| S:1891 E:1895 ||| MD
be  ||| S:1895 E:1898 ||| VB
responsible  ||| S:1898 E:1910 ||| JJ
for  ||| S:1910 E:1914 ||| IN
the  ||| S:1914 E:1918 ||| DT
action  ||| S:1918 E:1925 ||| NN
of  ||| S:1925 E:1928 ||| IN
treating  ||| S:1928 E:1937 ||| VBG
different  ||| S:1937 E:1947 ||| JJ
diseases  ||| S:1947 E:1956 ||| NNS
by  ||| S:1956 E:1959 ||| IN
the  ||| S:1959 E:1963 ||| DT
same  ||| S:1963 E:1968 ||| JJ
LWDH  ||| S:1968 E:1973 ||| NNP
formula ||| S:1973 E:1980 ||| NN
.  ||| S:1980 E:1982 ||| .
DMIM  ||| S:1982 E:1987 ||| NNP
is  ||| S:1987 E:1990 ||| VBZ
a  ||| S:1990 E:1992 ||| DT
powerful  ||| S:1992 E:2001 ||| JJ
method  ||| S:2001 E:2008 ||| NN
to  ||| S:2008 E:2011 ||| TO
identify  ||| S:2011 E:2020 ||| VB
the  ||| S:2020 E:2024 ||| DT
combination  ||| S:2024 E:2036 ||| NN
rule  ||| S:2036 E:2041 ||| NN
of  ||| S:2041 E:2044 ||| IN
herbal  ||| S:2044 E:2051 ||| JJ
formulae  ||| S:2051 E:2060 ||| NN
and  ||| S:2060 E:2064 ||| CC
lead  ||| S:2064 E:2069 ||| VB
to  ||| S:2069 E:2072 ||| TO
new  ||| S:2072 E:2076 ||| JJ
discoveries ||| S:2076 E:2087 ||| NNS
.  ||| S:2087 E:2089 ||| .
We  ||| S:2089 E:2092 ||| PRP
also  ||| S:2092 E:2097 ||| RB
provide  ||| S:2097 E:2105 ||| VB
the  ||| S:2105 E:2109 ||| DT
first  ||| S:2109 E:2115 ||| JJ
evidence  ||| S:2115 E:2124 ||| NN
that  ||| S:2124 E:2129 ||| IN
the  ||| S:2129 E:2133 ||| DT
co-module  ||| S:2133 E:2143 ||| JJ
across  ||| S:2143 E:2150 ||| IN
multilayer  ||| S:2150 E:2161 ||| JJ
networks  ||| S:2161 E:2170 ||| NNS
may  ||| S:2170 E:2174 ||| MD
underlie  ||| S:2174 E:2183 ||| VB
the  ||| S:2183 E:2187 ||| DT
combination  ||| S:2187 E:2199 ||| NN
mechanism  ||| S:2199 E:2209 ||| NN
of  ||| S:2209 E:2212 ||| IN
herbal  ||| S:2212 E:2219 ||| JJ
formulae  ||| S:2219 E:2228 ||| NN
and  ||| S:2228 E:2232 ||| CC
demonstrate  ||| S:2232 E:2244 ||| VB
the  ||| S:2244 E:2248 ||| DT
potential  ||| S:2248 E:2258 ||| NN
of  ||| S:2258 E:2261 ||| IN
network  ||| S:2261 E:2269 ||| NN
biology  ||| S:2269 E:2277 ||| NN
approaches  ||| S:2277 E:2288 ||| NNS
in  ||| S:2288 E:2291 ||| IN
the  ||| S:2291 E:2295 ||| DT
studies  ||| S:2295 E:2303 ||| NNS
of  ||| S:2303 E:2306 ||| IN
TCM ||| S:2306 E:2309 ||| NNP
.  ||| S:2309 E:2311 ||| .
